Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
13
×
life sciences
san diego blog main
san diego top stories
boston blog main
boston top stories
fda
national top stories
new york blog main
wisconsin blog main
biotech
new york top stories
san francisco blog main
san francisco top stories
wisconsin top stories
clinical trials
startups
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
boston
deals
eli lilly
national
san diego
software
tech
vc
wisconsin
biontech
boston scientific
What
time
13
×
fda
catch
deal
innovation
startup
watchlist
wi
approved
based
bio
cancer
comes
days
drug
friday
gone
headlines
heart
latest
madison
medical
medicine
new
patients
real
recent
rna
second
venture
wisconsin's
acquire
acutus
add
adding
adds
agency
ago
aimmune
airport
Language
unset
unknown
Current search:
time
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More
@xconomy.com
4 years ago
WI Watchlist: E-Scooters, CUNA Incubator, Curate Funding & More
@xconomy.com
4 years ago
Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
WI Watchlist: Amazon, JCI, Understory, Titan Spine, Eurofins
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
5 years ago
No Vital Signs Apparent at Wireless Health Specialist Awarepoint